{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T02:59:28Z","timestamp":1763348368577,"version":"3.40.5"},"reference-count":142,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2022,1,2]]},"DOI":"10.1080\/14740338.2021.1953467","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T18:16:14Z","timestamp":1625681774000},"page":"67-81","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Comparative analysis of the use and control of thalidomide in Brazil and different countries: is it possible to say there is safety?"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8680-7566","authenticated-orcid":false,"given":"Soraya Machado","family":"de Jesus","sequence":"first","affiliation":[{"name":"Postgraduate Program in Pharmaceutical Sciences, University of Bras\u00edlia, Bras\u00edlia, Distrito Federal, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4481-210X","authenticated-orcid":false,"given":"Rafael Santos","family":"Santana","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Bras\u00edlia, Bras\u00edlia, Distrito Federal, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5258-9684","authenticated-orcid":false,"given":"Silvana Nair","family":"Leite","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florian\u00f3polis, Santa Catarina, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199921030-00002"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-311X1999000100011"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.anpedi.2012.11.022"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1002\/bdrc.21096"},{"key":"cit0005","unstructured":"Moro A. Participa\u00e7\u00e3o Social e Regula\u00e7\u00e3o de Medicamentos: o Caso da Talidomida no Brasil. [Social Participation and Drug Regulation: the Case of Thalidomide in Brazil] [dissertation]. Curitiba (PR): Federal University of Paran\u00e1. 2017. Portuguese."},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1590\/s0104-59702017000300004"},{"key":"cit0007","unstructured":"Santos FLA Hist\u00f3ria da Talidomida no Brasil e a trajet\u00f3ria para conquista de direitos das pessoas com a S\u00edndrome Teratog\u00eanica. [The History of Thalidomide in Brazil and the path to achieving the rights of people with the Teratogenic Syndrome] [dissertation]. Ponta Grossa (SP): State University of Ponta Grossa. 2018. Portuguese."},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1970070411"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021735"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1097\/MCD.0b013e32835ffc58"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2015.03.007"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1177\/1753193418805249"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/10.3.247"},{"issue":"4","key":"cit0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/picr.PICR_89_17","volume":"9","author":"Hans M","year":"2018","journal-title":"Perspect Clin Res"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01248"},{"issue":"8","key":"cit0017","doi-asserted-by":"crossref","first-page":"e0008329","DOI":"10.1371\/journal.pntd.0008329","volume":"14","author":"SMd J","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"14","key":"cit0018","first-page":"15","volume":"52","author":"Sa\u00fade SDVE","year":"2021","journal-title":"Boletim Epidemiol\u00f3gico"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196563303"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90163-5"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91874-0"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19971219)73:3<251::AID-AJMG4>3.0.CO;2-V"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1557(199710)6:3+<S37::AID-PDS274>3.3.CO;2-R"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)88289-2"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1177\/030631200030001002"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1002\/pds.899"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629040-00003"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.19732"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1080\/14639230601097523"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1002\/bdra.20384"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.2165\/11318920-000000000-00000"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.3747\/co.v17i4.644"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2011.527331"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60054-8"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2014.887678"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1177\/2168479013516776"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-016-0501-2"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1265\/ehpm.10.9"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1159\/000064632"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962005000600010"},{"issue":"6","key":"cit0041","first-page":"719","volume":"45","author":"Iyer CG","year":"1971","journal-title":"Bull World Health Organ"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124020-00002"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1093\/shm\/15.1.137"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcs148"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0733-2"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.120941"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008678"},{"issue":"6","key":"cit0048","doi-asserted-by":"crossref","first-page":"895","DOI":"10.4103\/idoj.IDOJ_668_20","volume":"11","author":"Rao PN","year":"2020","journal-title":"Indian Dermatol Online J"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.3138\/cbmh.33.2.162-26062015"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2018.02.026"},{"key":"cit0051","unstructured":"Vianna FSL Talidomida no Brasil: vigil\u00e2ncia Epidemiol\u00f3gica, Teratog\u00eanese e Farmacogen\u00e9tica. [Thalidomide in Brazil: epidemiological Surveillance, Teratogenesis and Pharmacogenetics] [dissertation]. Porto Alegre (RS): Federal University of Rio Grande do Sul. 2013. Portuguese."},{"key":"cit0052","unstructured":"Lei n\u00ba 7.070, de 20 de dezembro de 1982. Disp\u00f5e sobre pens\u00e3o especial para os deficientes f\u00edsicos que especifica e d\u00e1 outras providencias [Law No. 7070, of December 20, 1982. Provides for special pension for the physically deficient that it specifies and makes other provisions]. Bras\u00edlia (DF): Presid\u00eancia da Rep\u00fablica; 1982 Dec 21 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0053","unstructured":"Portaria n\u00ba 354, de 15 de agosto de 1997. Regulamentar o registro, a produ\u00e7\u00e3o, a fabrica\u00e7\u00e3o, a comercializa\u00e7\u00e3o, a exposi\u00e7\u00e3o \u00e0 venda, a prescri\u00e7\u00e3o e a dispensa\u00e7\u00e3o dos produtos \u00e0 base de talidomida [Ordinance No. 354, of August 15, 1997. Regulates the registration, production, manufacturing, commercialization, sale, prescription, and dispensation of thalidomide-based products.]. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 1997 Aug 18 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0054","unstructured":"Lei n\u00ba 9.782, de 26 de janeiro de 1999. Define o Sistema Nacional de Vigil\u00e2ncia Sanit\u00e1ria, cria a Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria, e d\u00e1 outras provid\u00eancias [Law No. 9782, of January 26, 1999. Defines the National Sanitary Surveillance System, creates the National Health Surveillance Agency, and makes other provisions]. Bras\u00edlia (DF): Presid\u00eancia da Rep\u00fablica; 1999 Jan 27 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0055","unstructured":"Resolu\u00e7\u00e3o da Diretoria Colegiada n\u00ba 34, de 20 de abril de 2000. Disp\u00f5e sobre a utiliza\u00e7\u00e3o da Talidomida no tratamento da mieloma m\u00faltiplo refrat\u00e1rio a quimioterapia [Collegiate Board Resolution No. 34, of April 20, 2000. Provides on the use of Thalidomide in the treatment of multiple myeloma refractory to chemotherapy]. Bras\u00edlia (DF): Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria; 2000 Apr 20 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0056","unstructured":"Lei n\u00ba 10.651, de 16 de abril de 2003. Disp\u00f5e sobre o controle do uso da talidomida [Law No. 10651, of April 16, 2003. Provides on the control of the use of thalidomide]. Bras\u00edlia (DF): presid\u00eancia da Rep\u00fablica; 2003 Apr 17 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0057","unstructured":"Lei n\u00ba 12.190, de 13 de janeiro de 2010. Concede indeniza\u00e7\u00e3o por dano moral \u00e0s pessoas com defici\u00eancia f\u00edsica decorrente do uso da talidomida, altera a Lei no 7.070, de 20 de dezembro de 1982, e d\u00e1 outras provid\u00eancias [Law No. 12190, of January 13, 2010. Grants compensation for moral damage to people with physical disabilities resulting from the use of thalidomide, amends Law 7070 of December 20, 1982, among other provisions]. Bras\u00edlia (DF): presid\u00eancia da Rep\u00fablica; 2010 Jan 13 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0058","unstructured":"Resolu\u00e7\u00e3o da Diretoria Colegiada n\u00ba 11, de 22 de mar\u00e7o de 2011. Disp\u00f5e o controle da subst\u00e2ncia Talidomida e do medicamento que a contenha [Collegiate Board Resolution No. 11, of March 22, 2011. Provides for the control of the substance Thalidomide and the drug containing it]. Bras\u00edlia (DF): ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria; 2011 Mar 22 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0059","unstructured":"Portaria n\u00ba 298 de 21 de mar\u00e7o de 2013. Atualiza os protocolos de uso da Talidomida no tratamento da Doen\u00e7a Enxerto Contra Hospedeiro e do Mieloma M\u00faltiplo [Ordinance No. 298 of March 21, 2013. Updates the protocols for the use of Thalidomide in the treatment of Graft-versus-Host Disease and Multiple Myeloma]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade; 2013 Mar 22 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0060","unstructured":"Portaria n\u00ba 100, de 7 de fevereiro de 2013. Aprova o Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas do L\u00fapus Eritematoso Sist\u00eamico [Ordinance No. 100, of February 7, 2013. Approves the Clinical Protocol and Therapeutic Guidelines for Systemic Lupus Erythematosus]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade; 2013 Feb 02 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0061","unstructured":"Portaria n\u00ba 45 de 16 de dezembro de 2014. Torna p\u00fablica a decis\u00e3o de ampliar o uso da talidomida para tratamento da s\u00edndrome mielodispl\u00e1sica no \u00e2mbito do Sistema \u00danico de Sa\u00fade \u2013 SUS [rdinance No. 45 of December 16, 2014. Makes public the decision to expand the use of thalidomide for the treatment of myelodysplastic syndrome within the Unified Health System - SUS]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade; 2014 Dec 17 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0062","unstructured":"Resolu\u00e7\u00e3o da Diretoria Colegiada n\u00ba 50, de 11 de novembro de 2015. Disp\u00f5e sobre a atualiza\u00e7\u00e3o do Anexo III, Indica\u00e7\u00f5es previstas para tratamento com a Talidomida, da RDC n\u00ba 11, de 22 de mar\u00e7o de 2011 [Collegiate Board Resolution No. 50, of November 11, 2015. Provides for the update of Annex III, Indications for treatment with Thalidomide, from RDC No. 11, dated March 22, 2011]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade; 2015 Nov 12 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0063","unstructured":"Portaria n\u00ba 493, de 11 de junho de 2015. Aprova o Protocolo de uso da talidomida no tratamento da s\u00edndrome mielodispl\u00e1sica [Ordinance No. 493, of June 11, 2015. Approves the Protocol for the use of thalidomide in the treatment of myelodysplastic syndrome]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade; 2015 Jun 12 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0064","unstructured":"Portaria n\u00ba 2.436, de 21 de setembro de 2017. Aprova a Pol\u00edtica Nacional de Aten\u00e7\u00e3o B\u00e1sica, estabelecendo a revis\u00e3o de diretrizes para a organiza\u00e7\u00e3o da Aten\u00e7\u00e3o B\u00e1sica, no \u00e2mbito do Sistema \u00danico de Sa\u00fade (SUS) [Ordinance No. 2436, of September 21, 2017. Approves the National Policy for Primary Care, establishing the revision of guidelines for the organization of Primary Care, within the Unified Health System (SUS)]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade; 2017 Sep 22 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0065","unstructured":"Lei n\u00ba 13.638, de 22 de mar\u00e7o de 2018. Altera a Lei n\u00ba 8.686, de 20 de julho de 1993, para estabelecer novo valor para a pens\u00e3o especial devida \u00e0 pessoa com a defici\u00eancia f\u00edsica conhecida como S\u00edndrome da Talidomida, institu\u00edda pela Lei n\u00ba 7.070, de 20 de dezembro de 1982 [Law No. 13638, of March 22, 2018. Amends Law No. 8686, of July 20, 1993, to establish new value for the special pension due to the person with the physical disability known as Thalidomide Syndrome, instituted by Law No. 7070, of December 20, 1982]. Bras\u00edlia (DF): presid\u00eancia da Rep\u00fablica; 2018 Mar 23 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0066","unstructured":"FUNED - Talidomida [FUNED - Thalidomide]. [Internet]. Bras\u00edlia (DF): ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Consultas Medicamentos; [cited 2019 Oct 14]. Available from: https:\/\/consultas.anvisa.gov.br\/#\/medicamentos\/. Portuguese."},{"key":"cit0067","unstructured":"Talidomida [Thalidomide]. [Internet]. Belo Horizonte (MG): funda\u00e7\u00e3o Ezequiel Dias; [cited 2019 Oct 14]. Available from: http:\/\/www.funed.mg.gov.br\/talidomida\/. Portuguese."},{"key":"cit0068","unstructured":"Farmacovigil\u00e2ncia [Pharmacovigilance]. [Internet]. Bras\u00edlia (DF): ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria; [cited 2019 Oct 14]. Available from: http:\/\/portal.anvisa.gov.br\/farmacovigilancia?inheritRedirect=true. Portuguese."},{"key":"cit0069","unstructured":"Talidomida: orienta\u00e7\u00e3o para paciente [Thalidomide: patient Guide]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade; [cited 2019 Oct 14]. Available from: https:\/\/portalarquivos2.saude.gov.br\/images\/pdf\/2016\/novembro\/14\/2016-0393-Folder-Talidomida.pdf. Portuguese."},{"key":"cit0070","unstructured":"Sistema de Informa\u00e7\u00e3o sobre Mortalidade [Mortality Information System]. [Internet]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade. Departamento de An\u00e1lises de Sa\u00fade e Vigil\u00e2ncia de Doen\u00e7as N\u00e3o Transmiss\u00edveis; [cited 2019 Oct 14]. Available from: http:\/\/svs.aids.gov.br\/dantps\/cgiae\/sim\/apresentacao\/. Portuguese."},{"key":"cit0071","unstructured":"Estudo Colaborativo Latino-Americano de Malforma\u00e7\u00f5es Cong\u00eanitas [Latin American Collaborative Study of Congenital Malformations]. [Internet]. Rio de Janeiro\/Buenos Aires (RJ\/BA): ECLAMC, [cited 2019 Oct 14]. Available from: http:\/\/www.eclamc.org\/port\/index.php. Portuguese."},{"key":"cit0072","unstructured":"Sistema de Informa\u00e7\u00f5es de Nascidos Vivos [Live Births Information System]. [Internet]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade; [cited 2019 Oct 14]. Available from: http:\/\/datasus.saude.gov.br\/sistemas-e-aplicativos\/eventos-v\/sinasc-sistema-de-informacoes-de-nascidos-vivos. Portuguese."},{"key":"cit0073","unstructured":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Talidomida: orienta\u00e7\u00e3o para o uso controlado. [Thalidomide: guidance for controlled use]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade; 2014. Portuguese."},{"key":"cit0074","unstructured":"Associa\u00e7\u00e3o Brasileira das V\u00edtimas da Talidomida [Brazilian Thalidomide Victims Association]. [Internet]. Belo Horizonte (MG): ABVT; [cited 2019 Oct 14]. Available from: https:\/\/abvt.wordpress.com\/. Portuguese."},{"key":"cit0075","unstructured":"Associa\u00e7\u00e3o Brasileira de Portadores de S\u00edndrome de Talidomida [Brazilian Association of Thalidomide Syndrome\u2019s Victims]. [Internet]. S\u00e3o Paulo (SP): ABPST; [cited 2019 Oct 14]. Available from: http:\/\/www.talidomida.org.br\/. Portuguese."},{"key":"cit0076","unstructured":"Decreto-Lei n\u00ba 2.848, de 07 de dezembro de 1940. C\u00f3digo Penal [Decree-Law No. 2848, of December 7, 1940. Penal Code]. Bras\u00edlia (DF): presid\u00eancia da Rep\u00fablica; 1940 Dec 31 [cited 2019 Oct 14]. Portuguese."},{"key":"cit0077","unstructured":"What does FDA regulate? [Internet]. Washington (DC): food and Drug Administration. About FDA; [cited 2019 Oct 14]. Available from: https:\/\/www.fda.gov\/about-fda\/fda-basics\/what-does-fda-regulate."},{"key":"cit0078","unstructured":"Laws Enforced by FDA. [Internet]. Washington (DC): food and Drug Administration. Regulatory Information; 2018 Mar 29 [cited 2019 Oct 14]. Available from: https:\/\/www.fda.gov\/regulatory-information\/laws-enforced-fda."},{"key":"cit0079","unstructured":"Drugs FD-A-A. [Internet]. Washington (DC): Food and Drug Administration. Drug Databases; 1998 Jul 16 [cited 2019 Oct 14]. Available from: https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm?event=overview.process&ApplNo=020785."},{"key":"cit0080","unstructured":"Prescription Drug Labeling Resources. [Internet]. Washington (DC): food and Drug Administration. Laws, Acts, and Rules; 2019 Jul 01 [cited 2019 Oct 14]. Available from: https:\/\/www.fda.gov\/drugs\/laws-acts-and-rules\/prescription-drug-labeling-resources."},{"key":"cit0081","unstructured":"Risk Evaluation and Mitigation Strategies\u2502REMS. [Internet]. Washington (DC): Food and Drug Administration. Drug Safety and Availability; 2019 Aug 08 [cited 2019 Oct 14]. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/risk-evaluation-and-mitigation-strategies-rems."},{"key":"cit0082","unstructured":"Metropolitan Atlanta Congenital Defects Program (MACDP). [Internet]. Atlanta (GA): centers for Disease Control and Prevention. Research & Tracking; 2018 Dec 07 [cited 2019 Oct 14]. Available from: https:\/\/www.cdc.gov\/ncbddd\/birthdefects\/macdp.html."},{"key":"cit0083","unstructured":"Birth Defects Monitoring Program (BDMP). [Internet]. Atlanta (GA): centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report; 1983 Feb 01 [cited 2019 Oct 14]. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/00014666.htm."},{"key":"cit0084","unstructured":"Thalidomide Survivors in the US. [Internet]. Minneapolis (MN): US Thalidomide Survivors, [cited 2019 Oct 14]. Available from: https:\/\/usthalidomide.org."},{"key":"#cr-split#-cit0085.1","unstructured":"U.S. Reports: Roe v. Wade, 410 U.S. 113 (1973). [Internet]. Washington (DC): Library of Congress. Legislation"},{"key":"#cr-split#-cit0085.2","unstructured":"[cited 2019 Oct 14]. Available from: https:\/\/www.loc.gov\/item\/usrep410113\/."},{"key":"#cr-split#-cit0086.1","unstructured":"U.S. Reports: Planned Parenthood of Southeastern Pennsylvania v. Casey, 505 U.S. 833 (1992). [Internet]. Washington (DC): Library of Congress. Legislation"},{"key":"#cr-split#-cit0086.2","unstructured":"[cited 2019 Oct 14]. Available from: https:\/\/www.loc.gov\/item\/usrep505833\/."},{"key":"cit0087","unstructured":"Pharmaceuticals and Medical Devices Agency. [Internet]. Chiyoda-ku (TYO): PMDA, [cited 2019 Oct 14]. Available from: https:\/\/www.pmda.go.jp\/english\/index.html."},{"key":"cit0088","unstructured":"Drug Safety Research Unit Japan. Information for the operation of Safety Management system for Unapproved Drugs (SMUD). [Internet]. Chiyoda-ku (TYO): ministry of Health, Labour and Welfare of Japan, [cited 2019 Oct 14]. Available from: http:\/\/www.dsrujp.org\/smudinfo\/smudinformation_e.html."},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.5025\/hansen.86.91"},{"key":"cit0090","unstructured":"Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. [Internet]. Chiyoda-ku (TYO): ministry of Justice. Japanese Law Translation Database System; 2015 Mar 31 [cited 2019 Oct 14]. Available from: http:\/\/www.japaneselawtranslation.go.jp\/law\/list\/?ft=1&re=2&dn=1&ky=pharmaceutical+affairs&x=52&y=17&co=01\u00ed03."},{"key":"cit0091","unstructured":"Japan Society Obstetrics and Gynecology. [Internet]. Chuo-ku (TYO): JAOG, [cited 2019 Oct 14]. Available from: http:\/\/www.jsog.or.jp\/modules\/en\/index.php?content_id=1."},{"key":"cit0092","unstructured":"Thalidomide Welfare Center. [Internet]. Chiyoda-ku (TYO): Ishizue Foundation in Japan, [cited 2019 Oct 14]. Available from: http:\/\/www008.upp.so-net.ne.jp\/ishizue\/index.html."},{"key":"cit0093","unstructured":"Fact Sheet \u2013 pr THALOMID authorization for sale in Canada. [Internet]. Ottawa (ON): health Canada. Drug and health products; 2015 Apr 24 [cited 2019 Oct 14]. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/drug-products\/fact-sheets\/fact-sheet-thalomid-authorization-sale-canada.html."},{"key":"#cr-split#-cit0094.1","unstructured":"Controlled Drugs and Substances Act (S.C. 1996, c. 19). Ottawa (ON): health Canada. Consolidated Regulations"},{"key":"#cr-split#-cit0094.2","unstructured":"2019 Sep 19 [cited 2019 Oct 14]. Available from: https:\/\/laws-lois.justice.gc.ca\/eng\/acts\/c-38.8\/."},{"key":"cit0095","unstructured":"The Canadian Tragedy. [Internet]. Montreal (QB): Thalidomide Victims Association of Canada, [cited 2019 Oct 14]. Available from: https:\/\/thalidomide.ca\/en\/."},{"key":"cit0096","unstructured":"Consumer Packaging and Labelling Regulations (C.R.C., c. 417). Ottawa (ON): Health Canada. Consolidated regulations; 2019 Jun 17 [cited 2019 Oct 14]. Available from: https:\/\/laws.justice.gc.ca\/eng\/regulations\/C.R.C._c._417\/index.html."},{"key":"cit0097","unstructured":"Canadian Thalidomide Survivors Support Program. [Internet]. Waterloo (ON): canadian Thalidomide Survivors Program, [cited 2019 Oct 14]. Available from: https:\/\/tsspcanada.ca\/."},{"key":"cit0098","unstructured":"Central Drugs Standard Control Organization. [Internet]. New Delhi (DL): CDSCO. Drugs; [cited 2019 Oct 14]. Available from: https:\/\/cdscoonline.gov.in\/CDSCO\/Drugs."},{"key":"cit0099","unstructured":"National Leprosy Eradication Program. Disability Prevention and Medical Rehabilitation: guidelines for Primary, Secondary and Tertiary Level Care. [Internet]. India: central Leprosy Division; 2012. [cited 2021 Jun 14]. Available from: http:\/\/clinicalestablishments.gov.in\/WriteReadData\/516.pdf."},{"key":"cit0100","unstructured":"Medicine Brands for Generic \u2018Thalidomide.\u2019 India: medicine India. Medicine Brands; [cited 2019 Oct 14]. Available from: https:\/\/www.medicineindia.org\/brands-for-generic\/455\/thalidomide."},{"key":"cit0101","unstructured":"Leprosy\/Hansen Disease: management of reactions and prevention of disabilities. Geneva: world Health Organization; 2020. [cited 2021 Jun 14]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789290227595."},{"key":"cit0102","unstructured":"Comprehensive Newborn Screening (CNS) - Handbook for screening visible Birth Defects at all delivery points. India: national Health Mission; 2016. [cited 2019 Oct 14]. Available from: https:\/\/www.nhm.gov.in\/images\/pdf\/programmes\/RBSK\/Resource_Documents\/Birth_Defects_Handbook.pdf."},{"key":"cit0103","unstructured":"The Medical Termination of Pregnancy Act, 1971. [Internet]. New Delhi (DL): Ministry of Health & Family Welfare. Acts, Rules and Standards for Health Sector; 2016 Nov 04 [cited 2019 Oct 14]. Available from: https:\/\/main.mohfw.gov.in\/acts-rules-and-standards-health-sector\/acts\/mtp-act-1971."},{"key":"cit0104","unstructured":"Thalidomide Celgene. [Internet]. Amsterdam (NL): European Medicines Agency. Human regulatory; 2008 Jan 04 [cited 2019 Oct 14]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/thalidomide-celgene."},{"key":"cit0105","unstructured":"VOLUME 9A of The Rules Governing Medicinal Products in the European Union \u2013 guidelines on Pharmacovigilance for Medicinal Products for Human Use. United Kingdom: European Medicines Agency; 2008."},{"key":"cit0106","unstructured":"European Medicines Agency recommends the approval of thalidomide for the treatment of rare bone-marrow cancer. United Kingdom: european Medicines Agency; 2008."},{"key":"cit0107","unstructured":"Bortezomib and thalidomide for the first\u2011line treatment of multiple myeloma. [Internet]. Nottinghamshire (UK): national Institute for Health and Care Excellence. NICE Guidance; 2011 Jul 27 [cited 2019 Oct 14]. Available from: https:\/\/www.nice.org.uk\/guidance\/ta228."},{"key":"cit0108","unstructured":"European network of population-based registries for the epidemiological surveillance of congenital anomalies. [Internet]. European Union: EUROCAT, [cited 2019 Oct 14]. Available from: https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat."},{"key":"cit0109","unstructured":"National Congenital Anomaly and Rare Disease Registration Service. [Internet]. London (UK): Government UK. Health and social care; 2015 Mar 27 [cited 2019 Oct 14]. Available from: https:\/\/www.gov.uk\/guidance\/the-national-congenital-anomaly-and-rare-disease-registration-service-ncardrs."},{"key":"cit0110","unstructured":"Estudio Colaborativo Espa\u00f1ol de Malformaciones Cong\u00e9nitas [Spanish Collaborative Study of Congenital Malformations]. [Internet]. Madrid (ES): ECEMC; [cited 2019 Oct 14]. Available from: http:\/\/www.fundacion1000.es\/ecemc. Spanish."},{"key":"cit0111","unstructured":"Les registres des malformations cong\u00e9nitales [Birth defect registers]. [Internet]. Paris (ILF): sante Publique France; 2019 May 20 [cited 2019 Oct 14]. Available from: https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/maladies-de-la-mere-et-de-l-enfant\/anomalies-et-malformations-congenitales\/articles\/les-registres-des-malformations-congenitales. French."},{"key":"cit0112","unstructured":"Thalidomide. [Internet]. Cambridgeshire (UK): the Thalidomide Trust; [cited 2019 Oct 14]. Available from: https:\/\/www.thalidomidetrust.org\/."},{"key":"cit0113","unstructured":"Bundesverband Contergangesch\u00e4digter [Federal Association of Contergan Victims]. [Internet]. Munich (BY): thalidomide; [cited 2019 Oct 14]. Available from: https:\/\/contergan.de\/. German."},{"key":"cit0114","unstructured":"The Thalidomide Society. [Internet]. Bromley (UK): Thalidomide Society; [cited 2019 Oct 14]. Available from: https:\/\/www.thalidomidesociety.org\/."},{"key":"cit0115","unstructured":"Asociaci\u00f3n de V\u00edctimas de la Talidomida en Espa\u00f1a [Association of Victims of thalidomide in Spain]. [Internet]. Alcantarilla (MC): AVITE; [cited 2019 Oct 14]. Available from: https:\/\/www.avite.org\/. Spanish."},{"key":"cit0116","unstructured":"German Criminal Code. [Internet]. Mohrenstra\u00dfe (BE): federal Ministry of Justice and Consumer Protection. Laws on the Internet; 2019 Jun 19 [cited 2019 Oct 14]. Available from: http:\/\/www.gesetze-im-internet.de\/englisch_stgb\/englisch_stgb.html#StGB_000P218."},{"key":"cit0117","unstructured":"Abortion Act 1967. [Internet]. London (UK): UK Legislation. UK Public general Acts; 2013 Apr 01 [cited 2019 Oct 14]. Available from: http:\/\/www.legislation.gov.uk\/ukpga\/1967\/87\/section\/1."},{"key":"cit0118","unstructured":"Ley Org\u00e1nica 2\/2010, de 3 de marzo, de salud sexual y reproductiva y de la interrupci\u00f3n voluntaria del embarazo [Organic Law 2\/2010, of March 3, 2010, on sexual and reproductive health and the voluntary interruption of pregnancy]. [Internet]. Madrid (ES): agencia Estatal Boletin Oficial Del Estado. Legislati\u00f3n Consolidada; 2015 Sep 22 [cited 2019 Oct 14]. Available from: https:\/\/www.boe.es\/buscar\/act.php?id=BOE-A-2010-3514. Spanish."},{"key":"#cr-split#-cit0119.1","unstructured":"Abortion Legislation in Europe - Law No. 75-17 of January 1975. [Internet]. Washington (DC): library of Congress. Legislation. Legal Reports"},{"key":"#cr-split#-cit0119.2","unstructured":"2018 Dec 30 [cited 2019 Oct 14]. Available from: https:\/\/www.loc.gov\/law\/help\/abortion-legislation\/europe.php#germany."},{"issue":"36","key":"cit0120","first-page":"417","volume":"95","author":"World Health Organization","year":"2020","journal-title":"Weekly Epidemiological Rec"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00905-8"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31243-7"},{"key":"cit0123","unstructured":"Diretrizes para vigil\u00e2ncia, aten\u00e7\u00e3o e elimina\u00e7\u00e3o da Hansen\u00edase como problema de sa\u00fade p\u00fablica: manual t\u00e9cnico-operacional [Guidelines for surveillance, care, and elimination of leprosy as a public health problem: technical-operational manual]. Bras\u00edlia (DF): minist\u00e9rio da Sa\u00fade; 2016. Portuguese."},{"key":"cit0124","unstructured":"Sistema Eletr\u00f4nico do Servi\u00e7o de Informa\u00e7\u00f5es ao Cidad\u00e3o. Informa\u00e7\u00f5es sobre aquisi\u00e7\u00e3o, distribui\u00e7\u00e3o e casos de talidomida no Brasil [Electronic System of the Citizen Information Service. Information on thalidomide purchase, distribution, and cases in Brazil]. [Internet]. Bras\u00edlia (DF): controladoria-Geral da Uni\u00e3o; [cited 2020 Nov 22]. Available from: https:\/\/esic.cgu.gov.br\/sistema\/site\/index.aspx. Portuguese."},{"issue":"8","key":"cit0125","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jval.2012.06.019","volume":"15","author":"Lis Y","year":"2012","journal-title":"Value Health"},{"key":"cit0126","unstructured":"Guidance Document - Submission of Risk Management Plans and Follow-up Commitments. [Internet]. Ottawa (ON): health Canada. Drug and health products; 2015 Jun 26 [cited 2019 Oct 14]. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/reports-publications\/medeffect-canada\/guidance-document-submission-risk-management-plans-follow-commitments.htm."},{"key":"cit0127","unstructured":"Valproate and related substances [Internet]. Netherlands: european Medicines Agency; Medicines; 2018 Mar 21 [cited 2021 Jun 14]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/valproate-related-substances-0."},{"issue":"1","key":"cit0128","first-page":"41","volume":"37","author":"Mb M","year":"1966","journal-title":"Revista Brasileira de Leprologia"},{"key":"cit0129","unstructured":"Expert WHO Committee on Leprosy: eighth report. [Internet]. Geneva: world Health Organization; 2012 [cited 2019 Oct 14]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/75151."},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1590\/0103-11042018s105"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1590\/0103-11042018s104"},{"issue":"2","key":"cit0132","doi-asserted-by":"crossref","first-page":"13s","DOI":"10.11606\/S1518-8787.2017051007120","volume":"51","author":"Leite SN","year":"2017","journal-title":"Rev Sa\u00fade P\u00fablica"},{"issue":"12","key":"cit0133","doi-asserted-by":"crossref","first-page":"e0006622","DOI":"10.1371\/journal.pntd.0006622","volume":"9","author":"Pescarini JM","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"cit0134","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30260-8"},{"key":"cit0135","doi-asserted-by":"publisher","DOI":"10.1590\/S1414-81452011000100009"},{"key":"cit0136","doi-asserted-by":"publisher","DOI":"10.1590\/0103-1104201711219"},{"key":"cit0137","doi-asserted-by":"publisher","DOI":"10.5123\/S1679-49742017000400013"},{"key":"cit0138","doi-asserted-by":"publisher","DOI":"10.1590\/0103-11042018s115"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2021.1953467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T19:45:16Z","timestamp":1699213516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2021.1953467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,2]]}},"alternative-id":["10.1080\/14740338.2021.1953467"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2021.1953467","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"type":"print","value":"1474-0338"},{"type":"electronic","value":"1744-764X"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}